{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:08:06Z","timestamp":1776802086311,"version":"3.51.2"},"reference-count":64,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":345,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2023-JC-QN-0965"],"award-info":[{"award-number":["2023-JC-QN-0965"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Thyroid cancer is one of the most common endocrine diseases worldwide with phenotypic heterogeneity. Deubiquitinating enzymes (DUBs) participated in ubiquitin (Ub) conjugases-induced signal by removing Ub from the substrates. Dysregulation of DUBs are associated with cancer progression, including thyroid carcinoma. In this review, we outline the main classification and structure of DUBs, the expression of DUBs in thyroid cancer, the association of DUBs with survival, and the possible mechanism of DUBs in thyroid cancer progression. Finally, we summarized the development of USP specific inhibitors, the strategies for designing and identifying selective inhibitors.<\/jats:p>","DOI":"10.1093\/bfgp\/elaf022","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T13:03:30Z","timestamp":1764335010000},"source":"Crossref","is-referenced-by-count":1,"title":["Expression and role of deubiquitinating enzymes in thyroid carcinoma"],"prefix":"10.1093","volume":"24","author":[{"given":"Meiling","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University , NO 127 Changle West Road, Xi\u2019an Shaanxi 710032, \u00a0","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjiao","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University , NO 127 Changle West Road, Xi\u2019an Shaanxi 710032, \u00a0","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University , NO 127 Changle West Road, Xi\u2019an Shaanxi 710032, \u00a0","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-7532","authenticated-orcid":false,"given":"Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University , NO 127 Changle West Road, Xi\u2019an Shaanxi 710032, \u00a0","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"2025121211314596000_ref1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/a-1089-7870","article-title":"Updates on the Management of Thyroid Cancer","volume":"52","author":"Araque","year":"2020","journal-title":"Horm Metab Res"},{"key":"2025121211314596000_ref2","article-title":"Thyroid carcinoma: phenotypic features, underlying biology and potential relevance for targeting therapy","volume":"22","author":"Hu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025121211314596000_ref3","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.3390\/ijms22147746","article-title":"Expression and role of ubiquitin-specific peptidases in osteoblasts","volume":"22","author":"Hariri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025121211314596000_ref4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.drudis.2020.10.028","article-title":"The emerging nature of ubiquitin-specific protease 7 (USP7): a new target in cancer therapy","volume":"26","author":"Nininahazwe","year":"2021","journal-title":"Drug Discov Today"},{"key":"2025121211314596000_ref5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"2025121211314596000_ref6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.trecan.2019.08.005","article-title":"DUBs, hypoxia, and cancer","volume":"5","author":"Mennerich","year":"2019","journal-title":"Trends in cancer"},{"key":"2025121211314596000_ref7","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.molcel.2025.02.002","article-title":"A family of bacterial Josephin-like deubiquitinases with an irreversible cleavage mode","volume":"85","author":"Hermanns","year":"2025","journal-title":"Mol Cell"},{"key":"2025121211314596000_ref8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","article-title":"Deubiquitinases: from mechanisms to their inhibition by small molecules","volume":"82","author":"Lange","year":"2022","journal-title":"Mol Cell"},{"key":"2025121211314596000_ref9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dnarep.2019.02.005","article-title":"USP7: structure, substrate specificity, and inhibition","volume":"76","author":"Pozhidaeva","year":"2019","journal-title":"DNA Repair"},{"key":"2025121211314596000_ref10","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nsmb.3475","article-title":"Mechanism and regulation of the Lys6-selective deubiquitinase USP30","volume":"24","author":"Gersch","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"2025121211314596000_ref11","doi-asserted-by":"crossref","DOI":"10.3390\/biom12070910","article-title":"Structural and functional basis of JAMM deubiquitinating enzymes in disease","volume":"12","author":"Pan","year":"2022","journal-title":"Biomolecules"},{"key":"2025121211314596000_ref12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/viro.1994.1209","article-title":"Herpes simplex virus type 1 immediate-early protein Vmw110 binds strongly and specifically to a 135-kDa cellular protein","volume":"200","author":"Meredith","year":"1994","journal-title":"Virology"},{"key":"2025121211314596000_ref13","doi-asserted-by":"crossref","first-page":"111037","DOI":"10.1016\/j.mce.2020.111037","article-title":"USP7 promotes proliferation of papillary thyroid carcinoma cells through TBX3-mediated p57(KIP2) repression","volume":"518","author":"Xie","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"2025121211314596000_ref14","doi-asserted-by":"crossref","first-page":"114366","DOI":"10.1016\/j.celrep.2024.114366","article-title":"The phosphorylation-deubiquitination positive feedback loop of the CHK2-USP7 axis stabilizes p53 under oxidative stress","volume":"43","author":"Liu","year":"2024","journal-title":"Cell Rep"},{"key":"2025121211314596000_ref15","doi-asserted-by":"crossref","first-page":"e7632","DOI":"10.1371\/journal.pone.0007632","article-title":"Increasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markers","volume":"4","author":"Fontaine","year":"2009","journal-title":"PloS One"},{"key":"2025121211314596000_ref16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12020-022-03068-x","article-title":"USP13 genetics and expression in a family with thyroid cancer","volume":"77","author":"Maria","year":"2022","journal-title":"Endocrine"},{"key":"2025121211314596000_ref17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41419-025-07890-9","article-title":"USP14 and UCHL5 synergistically deubiquitinate PKCalpha and translocate NF-kappaB to promote the progression of anaplastic thyroid cancer","volume":"16","author":"Zhang","year":"2025","journal-title":"Cell Death Dis"},{"key":"2025121211314596000_ref18","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1038\/s41467-024-48173-9","article-title":"Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF\/MAPK-mediated tumorigenesis","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"2025121211314596000_ref19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1620\/tjem.255.203","article-title":"Downregulated expression of USP18 is associated with a higher recurrence risk of papillary thyroid carcinoma","volume":"255","author":"Liang","year":"2021","journal-title":"Tohoku J Exp Med"},{"key":"2025121211314596000_ref20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41467-022-35348-5","article-title":"Expansion of interferon inducible gene pool via USP18 inhibition promotes cancer cell pyroptosis","volume":"14","author":"Arimoto","year":"2023","journal-title":"Nat Commun"},{"key":"2025121211314596000_ref21","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s13277-013-0696-0","article-title":"Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma","volume":"34","author":"Wang","year":"2013","journal-title":"Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"2025121211314596000_ref22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s10495-023-01809-5","article-title":"Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications","volume":"28","author":"Li","year":"2023","journal-title":"Apoptosis : An International Journal on Programmed Cell Death"},{"key":"2025121211314596000_ref23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41419-022-04781-1","article-title":"USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ","volume":"13","author":"Tang","year":"2022","journal-title":"Cell Death Dis"},{"key":"2025121211314596000_ref24","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1159\/000488041","article-title":"USP33 is a biomarker of disease recurrence in papillary thyroid carcinoma","volume":"45","author":"Jia","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2025121211314596000_ref25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1172\/JCI18348","article-title":"Deubiquitination of type 2 iodothyronine deiodinase by von Hippel\u2013Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation","volume":"112","author":"Curcio-Morelli","year":"2003","journal-title":"J Clin Investig"},{"key":"2025121211314596000_ref26","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.7150\/ijbs.99817","article-title":"USP44 inactivation accelerates the progression of thyroid cancer by inducing ubiquitylation and degradation of p21","volume":"20","author":"Liu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"2025121211314596000_ref27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nature10911","article-title":"The mechanism of OTUB1-mediated inhibition of ubiquitination","volume":"483","author":"Wiener","year":"2012","journal-title":"Nature"},{"key":"2025121211314596000_ref28","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1111\/jcmm.17020","article-title":"The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization","volume":"25","author":"Xie","year":"2021","journal-title":"J Cell Mol Med"},{"key":"2025121211314596000_ref29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/bjc.2014.331","article-title":"A putative OTU domain-containing protein 1 deubiquitinating enzyme is differentially expressed in thyroid cancer and identifies less-aggressive tumours","volume":"111","author":"Carneiro","year":"2014","journal-title":"Br J Cancer"},{"key":"2025121211314596000_ref30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41418-023-01134-z","article-title":"The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through hippo signaling pathway","volume":"30","author":"Tang","year":"2023","journal-title":"Cell Death Differ"},{"key":"2025121211314596000_ref31","doi-asserted-by":"crossref","first-page":"111440","DOI":"10.1016\/j.mce.2021.111440","article-title":"The deubiquitinating enzyme ATXN3 promotes the progression of anaplastic thyroid carcinoma by stabilizing EIF5A2","volume":"537","author":"Zhuang","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"2025121211314596000_ref32","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1038\/s41388-022-02499-0","article-title":"Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability","volume":"41","author":"Hong","year":"2022","journal-title":"Oncogene"},{"key":"2025121211314596000_ref33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00262-025-04101-4","article-title":"Single-cell RNA sequencing and multi-omics analysis of prognosis-related staging in papillary thyroid cancer","volume":"74","author":"Ji","year":"2025","journal-title":"Cancer immunology, immunotherapy : CII"},{"key":"2025121211314596000_ref34","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/jamaoncol.2024.4019","article-title":"Dual immune checkpoint inhibition in patients with aggressive thyroid carcinoma: a phase 2 nonrandomized clinical trial","volume":"10","author":"Sehgal","year":"2024","journal-title":"JAMA Oncol"},{"key":"2025121211314596000_ref35","doi-asserted-by":"crossref","first-page":"217624","DOI":"10.1016\/j.canlet.2025.217624","article-title":"UBE2C mediates follicular thyroid carcinoma invasion and metastasis via K29-specific vimentin ubiquitination","volume":"617","author":"Xu","year":"2025","journal-title":"Cancer Lett"},{"key":"2025121211314596000_ref36","first-page":"1451","article-title":"Progress in treating advanced thyroid cancers in the era of targeted therapy","volume":"31","author":"Lubitz","year":"2021","journal-title":"Thyroid : Official Journal of the American Thyroid Association"},{"key":"2025121211314596000_ref37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.freeradbiomed.2025.02.025","article-title":"N6-methyladenosine-mediated EIF3H promotes anaplastic thyroid cancer progression and ferroptosis resistance by stabilizing beta-catenin","volume":"231","author":"Zhang","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"2025121211314596000_ref38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41568-023-00598-y","article-title":"Pathogenesis of cancers derived from thyroid follicular cells","volume":"23","author":"Fagin","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"2025121211314596000_ref39","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1158\/1535-7163.MCT-21-0037","article-title":"Beta-catenin attenuation inhibits tumor growth and promotes differentiation in a BRAF(V600E)-driven thyroid cancer animal model","volume":"20","author":"Zou","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"2025121211314596000_ref40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12943-022-01676-9","article-title":"Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors","volume":"21","author":"Garcia-Rendueles","year":"2022","journal-title":"Mol Cancer"},{"key":"2025121211314596000_ref41","doi-asserted-by":"crossref","article-title":"Regulation of proteolysis by human deubiquitinating enzymes","author":"Eletr","DOI":"10.1016\/j.bbamcr.2013.06.027"},{"key":"2025121211314596000_ref42","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1517\/13543776.2015.1056737","article-title":"Deubiquitinases (DUBs) and DUB inhibitors: a patent review","volume":"25","author":"Farshi","year":"2015","journal-title":"Expert Opin Ther Pat"},{"key":"2025121211314596000_ref43","first-page":"2731","article-title":"Advances in discovering deubiquitinating enzyme (DUB)","volume":"63","author":"Schauer","year":"2020","journal-title":"Inhibitors."},{"key":"2025121211314596000_ref44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/9780470559277.ch120078","article-title":"A high-throughput screening method for identification of inhibitors of the deubiquitinating enzyme USP14","volume":"4","author":"Lee","year":"2012","journal-title":"Current protocols in chemical biology"},{"key":"2025121211314596000_ref45","volume-title":"Discovery of ML323 as a Novel Inhibitor of the USP1\/UAF1 Deubiquitinase Complex. Probe Reports from the NIH Molecular Libraries Program","author":"Dexheimer","year":"2010"},{"key":"2025121211314596000_ref46","doi-asserted-by":"crossref","first-page":"103962","DOI":"10.1016\/j.bioorg.2020.103962","article-title":"Discovery of novel USP8 inhibitors via ubiquitin-Rho-110 fluorometric assay based high throughput screening","volume":"101","author":"Han","year":"2020","journal-title":"Bioorg Chem"},{"key":"2025121211314596000_ref47","doi-asserted-by":"crossref","first-page":"101107","DOI":"10.1016\/j.jbc.2021.101107","article-title":"Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1","volume":"297","author":"Guo","year":"2021","journal-title":"J Biol Chem"},{"key":"2025121211314596000_ref48","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1038\/ncomms5763","article-title":"Screening of DUB activity and specificity by MALDI-TOF mass spectrometry","volume":"5","author":"Ritorto","year":"2014","journal-title":"Nat Commun"},{"key":"2025121211314596000_ref49","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1074\/mcp.M700505-MCP200","article-title":"In-cell selectivity profiling of serine protease inhibitors by activity-based proteomics","volume":"7","author":"Gillet","year":"2008","journal-title":"Molecular & cellular proteomics : MCP"},{"key":"2025121211314596000_ref50","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.chembiol.2011.08.018","article-title":"Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes","volume":"18","author":"Altun","year":"2011","journal-title":"Chem Biol"},{"key":"2025121211314596000_ref51","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.chembiol.2017.09.003","article-title":"Structure-guided development of a potent and selective non-covalent active-site inhibitor of USP7","volume":"24","author":"Lamberto","year":"2017","journal-title":"Cell chemical biology"},{"key":"2025121211314596000_ref52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature24451","article-title":"Molecular basis of USP7 inhibition by selective small-molecule inhibitors","volume":"550","author":"Turnbull","year":"2017","journal-title":"Nature"},{"key":"2025121211314596000_ref53","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/13543776.2022.2058873","article-title":"A patent review of ubiquitin-specific protease 7 (USP7) inhibitors (2014-present)","volume":"32","author":"Li","year":"2022","journal-title":"Expert Opin Ther Pat"},{"key":"2025121211314596000_ref54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front Endocrinol"},{"key":"2025121211314596000_ref55","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2741\/4359","article-title":"The role of BRAF in the pathogenesis of thyroid carcinoma","volume":"20","author":"Li","year":"2015","journal-title":"Frontiers in bioscience (Landmark edition)"},{"key":"2025121211314596000_ref56","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2025121211314596000_ref57","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1089\/thy.2014.0053","article-title":"NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma","volume":"24","author":"Jang","year":"2014","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"key":"2025121211314596000_ref58","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/ERC-15-0533","article-title":"TERT promoter mutations in thyroid cancer","volume":"23","author":"Liu","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"2025121211314596000_ref59","doi-asserted-by":"crossref","first-page":"e0153319","DOI":"10.1371\/journal.pone.0153319","article-title":"BRAF V600E and TERT promoter mutations in papillary thyroid carcinoma in Chinese patients","volume":"11","author":"Sun","year":"2016","journal-title":"PloS One"},{"key":"2025121211314596000_ref60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13000-019-0849-6","article-title":"Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China","volume":"14","author":"Huang","year":"2019","journal-title":"Diagn Pathol"},{"key":"2025121211314596000_ref61","doi-asserted-by":"crossref","first-page":"125867","DOI":"10.1016\/j.ijbiomac.2023.125867","article-title":"Pin1 inhibitor API-1 sensitizes BRAF-mutant thyroid cancers to BRAF inhibitors by attenuating HER3-mediated feedback activation of MAPK\/ERK and PI3K\/AKT pathways","volume":"248","author":"Dang","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"2025121211314596000_ref62","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1016\/j.molcel.2022.10.016","article-title":"RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation","volume":"82","author":"Spencer-Smith","year":"2022","journal-title":"Mol Cell"},{"key":"2025121211314596000_ref63","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gutjnl-2021-324852","article-title":"Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment","volume":"71","author":"Wang","year":"2022","journal-title":"Gut"},{"key":"2025121211314596000_ref64","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s12276-022-00887-w","article-title":"The equilibrium of tumor suppression: DUBs as active regulators of PTEN","volume":"54","author":"Christine","year":"2022","journal-title":"Exp Mol Med"}],"container-title":["Briefings in Functional Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bfg\/article-pdf\/doi\/10.1093\/bfgp\/elaf022\/65855681\/elaf022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bfg\/article-pdf\/doi\/10.1093\/bfgp\/elaf022\/65855681\/elaf022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T16:32:00Z","timestamp":1765557120000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bfg\/article\/doi\/10.1093\/bfgp\/elaf022\/8378200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":64,"URL":"https:\/\/doi.org\/10.1093\/bfgp\/elaf022","relation":{},"ISSN":["2041-2649","2041-2657"],"issn-type":[{"value":"2041-2649","type":"print"},{"value":"2041-2657","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"elaf022"}}